JP2007506679A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007506679A5 JP2007506679A5 JP2006527053A JP2006527053A JP2007506679A5 JP 2007506679 A5 JP2007506679 A5 JP 2007506679A5 JP 2006527053 A JP2006527053 A JP 2006527053A JP 2006527053 A JP2006527053 A JP 2006527053A JP 2007506679 A5 JP2007506679 A5 JP 2007506679A5
- Authority
- JP
- Japan
- Prior art keywords
- methoxy
- methyl
- group
- oxo
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50521503P | 2003-09-23 | 2003-09-23 | |
| US60/505,215 | 2003-09-23 | ||
| PCT/US2004/030484 WO2005030726A1 (en) | 2003-09-23 | 2004-09-17 | Isoquinolinone potassium channel inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007506679A JP2007506679A (ja) | 2007-03-22 |
| JP2007506679A5 true JP2007506679A5 (enExample) | 2007-10-25 |
| JP4717815B2 JP4717815B2 (ja) | 2011-07-06 |
Family
ID=34392991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006527053A Expired - Fee Related JP4717815B2 (ja) | 2003-09-23 | 2004-09-17 | イソキノリノンカリウムチャネル阻害剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7741322B2 (enExample) |
| EP (1) | EP1667976B1 (enExample) |
| JP (1) | JP4717815B2 (enExample) |
| CN (1) | CN1856472A (enExample) |
| AT (1) | ATE476419T1 (enExample) |
| AU (1) | AU2004276238B2 (enExample) |
| CA (1) | CA2539729C (enExample) |
| DE (1) | DE602004028493D1 (enExample) |
| WO (1) | WO2005030726A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004276236B2 (en) * | 2003-09-23 | 2008-01-24 | Merck Sharp & Dohme Corp. | Isoquinolinone potassium channel inhibitors |
| EP1667978B1 (en) * | 2003-09-23 | 2013-09-04 | Merck Sharp & Dohme Corp. | Isoquinolinone potassium channel inhibitors |
| US7763614B2 (en) * | 2003-09-23 | 2010-07-27 | Merck Sharp & Dohme Corp. | Isoquinoline potassium channel inhibitors |
| WO2005030727A1 (en) * | 2003-09-23 | 2005-04-07 | Merck & Co., Inc. | Isoquinolinone potassium channel inhibitors |
| US7569589B2 (en) | 2004-07-29 | 2009-08-04 | Merck & Co., Inc. | Potassium channel inhibitors |
| AU2005267884B2 (en) | 2004-07-29 | 2011-04-21 | Merck Sharp & Dohme Corp. | Potassium channel inhibitors |
| EP1922311A2 (en) | 2005-09-09 | 2008-05-21 | Brystol-Myers Squibb Company | Acyclic ikur inhibitors |
| EP1996198A1 (en) * | 2006-03-17 | 2008-12-03 | Kalypsys, Inc. | Alkylamine-substituted bicyclic aryl compounds useful as modulators of ppar |
| DE102006019589A1 (de) * | 2006-04-27 | 2007-10-31 | Sanofi-Aventis Deutschland Gmbh | Inhibitoren des TASK-1 und Task-3 Ionenkanals |
| BRPI0806371A2 (pt) | 2007-01-22 | 2011-09-13 | Gtx Inc | agentes ligação de receptor nuclear |
| US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
| US9623021B2 (en) * | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
| CA3072648A1 (en) * | 2017-08-14 | 2019-02-21 | Acesion Pharma Aps | Substituted benzimidazoles as potassium channel inhibitors |
| CN110670090B (zh) * | 2019-11-13 | 2021-06-29 | 广西师范大学 | 一种基于电化学合成异喹啉酮类化合物的方法 |
| EP4444305A2 (en) * | 2022-02-16 | 2024-10-16 | Duke Street Bio Limited | Pharmaceutical compound |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3594380A (en) * | 1969-02-18 | 1971-07-20 | American Home Prod | Isoquinolin-1(2h)-ones |
| NO179904C (no) | 1992-09-04 | 1997-01-08 | Takeda Chemical Industries Ltd | Kondenserte heterocykliske forbindelser og deres anvendelse |
| EP0634402A1 (en) * | 1993-07-14 | 1995-01-18 | Takeda Chemical Industries, Ltd. | Isochinolinone derivatives, their production and use |
| US5387685A (en) | 1993-07-16 | 1995-02-07 | American Cyanamid Co | MDR reversal agents |
| AU2002212969B2 (en) | 2000-09-20 | 2006-07-06 | Merck Sharp & Dohme Corp. | Isoquinolinone potassium channel inhibitors |
| WO2002094790A1 (en) * | 2001-05-23 | 2002-11-28 | Mitsubishi Pharma Corporation | Fused heterocyclic compound and medicinal use thereof |
| US7402595B2 (en) * | 2002-02-13 | 2008-07-22 | Takeda Pharmaceutical Company Limited | JNK inhibitor |
| AU2004276236B2 (en) * | 2003-09-23 | 2008-01-24 | Merck Sharp & Dohme Corp. | Isoquinolinone potassium channel inhibitors |
| WO2005030727A1 (en) * | 2003-09-23 | 2005-04-07 | Merck & Co., Inc. | Isoquinolinone potassium channel inhibitors |
| US7763614B2 (en) * | 2003-09-23 | 2010-07-27 | Merck Sharp & Dohme Corp. | Isoquinoline potassium channel inhibitors |
| EP1667978B1 (en) * | 2003-09-23 | 2013-09-04 | Merck Sharp & Dohme Corp. | Isoquinolinone potassium channel inhibitors |
-
2004
- 2004-09-17 WO PCT/US2004/030484 patent/WO2005030726A1/en not_active Ceased
- 2004-09-17 US US10/571,858 patent/US7741322B2/en not_active Expired - Fee Related
- 2004-09-17 EP EP04784368A patent/EP1667976B1/en not_active Expired - Lifetime
- 2004-09-17 AT AT04784368T patent/ATE476419T1/de not_active IP Right Cessation
- 2004-09-17 JP JP2006527053A patent/JP4717815B2/ja not_active Expired - Fee Related
- 2004-09-17 AU AU2004276238A patent/AU2004276238B2/en not_active Ceased
- 2004-09-17 CA CA2539729A patent/CA2539729C/en not_active Expired - Fee Related
- 2004-09-17 DE DE602004028493T patent/DE602004028493D1/de not_active Expired - Lifetime
- 2004-09-17 CN CNA2004800273770A patent/CN1856472A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007506679A5 (enExample) | ||
| RU2203897C2 (ru) | Производные бензамидина, способ их получения, фармацевтическая композиция, способ ее получения и лекарственное средство | |
| JP2007507551A5 (enExample) | ||
| NO20081970L (no) | Sulfonamidderivat med PGD2-reseptorantagonistaktivitet | |
| JP2006523627A5 (enExample) | ||
| WO2013009830A1 (en) | Methods of treatment | |
| RU2013138569A (ru) | Антагонисты рецептора минералокортикоидов | |
| WO2013009810A1 (en) | Methods of treatment | |
| NZ603724A (en) | Piperidine derivatives and their use for the treatment of metabolic disorders | |
| KR20150135359A (ko) | 브로모도메인-함유 단백질의 억제를 위한 방법 및 조성물 | |
| CA2543602A1 (en) | Triazole compounds and uses related thereto | |
| JP2007513915A5 (enExample) | ||
| CN110062757A (zh) | 凝血因子XIa抑制剂及其用途 | |
| RU2009138219A (ru) | Новые бензамидные производные и способ их получения | |
| IL205501A (en) | Preparation of preparations for the treatment of arthritis | |
| RU2018104868A (ru) | 2-амино-3-фтор-3-(фторметил)-6-метил-6-фенил-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1 | |
| KR102540872B1 (ko) | 나프티리디논 유도체 및 부정맥의 치료에서의 이들의 용도 | |
| JP2014506590A5 (enExample) | ||
| CN102803214A (zh) | 新化合物、与之相关的药物组合物和方法 | |
| JP2011506501A5 (enExample) | ||
| CA2539729A1 (en) | Isoquinolinone potassium channel inhibitors | |
| JP2007506748A5 (enExample) | ||
| CA2539541A1 (en) | Isoquinolinone potassium channel inhibitors | |
| JP2017500321A5 (enExample) | ||
| FI3827829T3 (fi) | Ei-alkoholiperäisen rasvamaksan ehkäisyssä tai hoidossa käytettävä lääkekoostumus, joka sisältää vaikuttavana aineena gpr119-ligandin |